当前位置:首页 - 行情中心 - 蓝丰生化(002513) - 财务分析 - 利润表

蓝丰生化

(002513)

  

流通市值:9.98亿  总市值:14.13亿
流通股本:2.64亿   总股本:3.74亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入763,015,745.63526,523,779.66381,711,743.061,445,239,989.37
营业收入763,015,745.63526,523,779.66381,711,743.061,445,239,989.37
二、营业总成本887,530,111.18616,584,696.01401,308,232.651,564,314,455.25
营业成本743,357,641.04517,084,729.31367,748,653.931,435,811,322.85
税金及附加4,192,393.912,822,799.451,577,437.95,808,254.82
销售费用8,661,496.436,050,409.894,151,556.3713,562,981.02
管理费用107,445,235.165,205,486.6523,146,227.7590,691,838.38
研发费用6,487,821.434,527,513.382,645,482.2211,651,282.22
财务费用17,385,523.2720,893,757.332,038,874.486,788,775.96
其中:利息费用19,680,312.7919,680,312.79-13,554,511.14
其中:利息收入30,586.7430,586.74-7,755,575.15
加:投资收益377,584.73377,584.73-2,309,619.93
资产处置收益4,587,799.445,254,817.854,858,685.441,471,187.14
资产减值损失(新)-12,026,227.89-4,897,689.86--15,983,520.04
信用减值损失(新)-4,749,971.81-3,760,283.57-7,250,716.9-51,615,476.82
其他收益4,695,645.562,709,805.642,110,9502,432,593.79
营业利润平衡项目0000
四、营业利润-131,629,535.52-90,376,681.56-19,877,571.05-180,460,061.88
加:营业外收入2,478,153.671,438,685.97818,075.343,982,961.42
减:营业外支出10,355,487.18300,807.03104,921.4870,491,530.65
利润总额平衡项目0000
五、利润总额-139,506,869.03-89,238,802.62-19,164,417.19-246,968,631.11
减:所得税费用-3,525,280.172,425,280.24-4,349,530.7473,723,869.46
六、净利润-135,981,588.86-91,664,082.86-14,814,886.45-320,692,500.57
持续经营净利润-135,981,588.86-91,664,082.86-14,814,886.45-320,692,500.57
归属于母公司股东的净利润-135,974,730.81-91,660,727.95-14,727,136.62-320,692,444.11
少数股东损益-6,858.05-3,354.91-87,749.83-56.46
(一)基本每股收益-0.36-0.25-0.04-0.86
(二)稀释每股收益-0.36-0.25-0.04-0.86
八、其他综合收益278,033.23278,033.23-182,412.37
归属于母公司股东的其他综合收益278,033.23278,033.23-182,412.37
九、综合收益总额-135,703,555.63-91,386,049.63-14,814,886.45-320,510,088.2
归属于母公司股东的综合收益总额-135,696,697.58-91,382,694.72-14,727,136.62-320,510,031.74
归属于少数股东的综合收益总额-6,858.05-3,354.91-87,749.83-56.46
公告日期2023-10-312023-08-312023-04-292023-04-27
审计意见(境内)标准无保留意见
TOP↑